D&C Biotechnology
Seoul, South Korea
D&C Biotechnology is a leading company in the global in vitro diagnostic device market, specializing in the development and production of next-generation urine analyzers. The company is committed to improving medical environments and protecting family health through innovative healthcare solutions. Their products focus on delivering faster, more accurate, easier, and safer diagnostic results. In addition to their flagship urine analyzer, D&C Biotechnology is actively engaged in research and development to advance digital healthcare, collaborating with partners to enhance the effectiveness of medical diagnostics. The company also emphasizes environmental, social, and governance (ESG) initiatives as a core part of its mission.
Only accessible to MedStartr community members.
Join nowCompany Info
- Founded
- 2021
- Website
- dncbiotechnology.com/
Only accessible to MedStartr community members.
Join nowWhat do you think of D&C Biotechnology?
A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.
Only accessible to MedStartr community members.
Join now